Preclinical evaluation of intravenous NAX 810-2, a novel GalR2-preferring analog, for anticonvulsant efficacy and pharmacokinetics.

about

Novel Targets for Developing Antiseizure and, Potentially, Antiepileptogenic Drugs.A resurging boom in new drugs for epilepsy and brain disorders.Preclinical Analgesic and Safety Evaluation of the GalR2-preferring Analog, NAX 810-2.

P2860

Q47139898-B4CE0198-3204-4B51-A7F2-B46B78F03757 Q48093388-467ADE1B-AF21-44A6-BA89-F9F4B1050BDD Q52099813-A82F0902-F17B-4A73-BA13-DCCA580082C2

P2860

Preclinical evaluation of intravenous NAX 810-2, a novel GalR2-preferring analog, for anticonvulsant efficacy and pharmacokinetics.

Item

http://www.wikidata.org/entity/Q48352136

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Preclinical evaluation of intr ...... efficacy and pharmacokinetics.

@en

Preclinical evaluation of intr ...... efficacy and pharmacokinetics.

@nl

type

Item

label

Preclinical evaluation of intr ...... efficacy and pharmacokinetics.

@en

Preclinical evaluation of intr ...... efficacy and pharmacokinetics.

@nl

prefLabel

Preclinical evaluation of intr ...... efficacy and pharmacokinetics.

@en

Preclinical evaluation of intr ...... efficacy and pharmacokinetics.

@nl

P1476

Preclinical evaluation of intr ...... efficacy and pharmacokinetics.

@en

P2093

Brian D Klein

http://www.w3.org/2001/XMLSchema#string

Dan Kaufmann

http://www.w3.org/2001/XMLSchema#string

Daniel R McDougle

http://www.w3.org/2001/XMLSchema#string

Grzegorz Bulaj

http://www.w3.org/2001/XMLSchema#string

H Steve White

http://www.w3.org/2001/XMLSchema#string

Liuyin Zhang

http://www.w3.org/2001/XMLSchema#string

P2860

Anticonvulsant activity of a nonpeptide galanin receptor agonist.

Patterns of seizures, hippocampal injury and neurogenesis in three models of status epilepticus in galanin receptor type 1 (GalR1) knockout mice.

Synthesis of galmic: a nonpeptide galanin receptor agonist

The synaptic vesicle protein SV2A is the binding site for the antiepileptic drug levetiracetam

Galmic, a nonpeptide galanin receptor agonist, affects behaviors in seizure, pain, and forced-swim tests

Progress report on new antiepileptic drugs: a summary of the Eleventh Eilat Conference (EILAT XI)

Regulators of synaptic transmission: roles in the pathogenesis and treatment of epilepsy

Positive allosteric modulators to peptide GPCRs: a promising class of drugs

Modification of seizure activity by electrical stimulation. II. Motor seizure

Developing novel antiepileptic drugs: characterization of NAX 5055, a systemically-active galanin analog, in epilepsy models

P304

239-246

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/EPI.13647

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Cameron S Metcalf

P577

2017-01-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28098336

http://www.w3.org/2001/XMLSchema#string

P932

5291807

http://www.w3.org/2001/XMLSchema#string

Preclinical evaluation of intravenous NAX 810-2, a novel GalR2-preferring analog, for anticonvulsant efficacy and pharmacokinetics.

about

P2860

P2860

Preclinical evaluation of intravenous NAX 810-2, a novel GalR2-preferring analog, for anticonvulsant efficacy and pharmacokinetics.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P932